El tratamiento del factor XIII para la esclerodermia.

Same author

Modification of serum proteins during the early stages of undernutrition.

Comptes rendus des seances de la Societe de biologie et de ses filiales·2010

Same author

Some remarks on the research of phenylpyruvic acid in the urine.

Comptes rendus des seances de la Societe de biologie et de ses filiales·2010

Same author

Carbohydrate metabolism disorders in active chronic polyarthritis.

Bulletins et memoires de la Societe medicale des hopitaux de Paris·2010

Same author

Action of the adrenochromic semicarbazone on the glycemia of normal humans.

Annales de biologie clinique·2010

Same author

Treatment of progressive systemic sclerosis using factor XIII.

Pharmatherapeutica·1985

Same author

Manganese-containing superoxide-dismutase deficiency in polymorphonuclear leukocytes of adults with rheumatoid arthritis.

Inflammation·1984

Same journal

Rethinking anticoagulation intensity during extracorporeal membrane oxygenation.

Lancet (London, England)·2026

Same journal

Standard-dose unfractionated heparin versus low-dose unfractionated heparin and low-molecular-weight heparin in extracorporeal life support (RATE): an open-label, randomised, non-inferiority trial.

Lancet (London, England)·2026

Same journal

Inherited retinal degenerations: clinical phenotypes and emerging therapies.

Lancet (London, England)·2026

Same journal

Documenting hospice care.

Lancet (London, England)·2026

Same journal

After the wood chipper.

Lancet (London, England)·2026

Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026

Videos de Experimentos Relacionados

El tratamiento del factor XIII para la esclerodermia.

Videos de Conceptos Relacionados

Modification of serum proteins during the early stages of undernutrition.

Some remarks on the research of phenylpyruvic acid in the urine.

Carbohydrate metabolism disorders in active chronic polyarthritis.

Action of the adrenochromic semicarbazone on the glycemia of normal humans.

Treatment of progressive systemic sclerosis using factor XIII.

Manganese-containing superoxide-dismutase deficiency in polymorphonuclear leukocytes of adults with rheumatoid arthritis.

Rethinking anticoagulation intensity during extracorporeal membrane oxygenation.

Standard-dose unfractionated heparin versus low-dose unfractionated heparin and low-molecular-weight heparin in extracorporeal life support (RATE): an open-label, randomised, non-inferiority trial.

Inherited retinal degenerations: clinical phenotypes and emerging therapies.

Documenting hospice care.

After the wood chipper.

Assisted dying and the silencing of medicine's next generation.

Videos de Experimentos Relacionados

El tratamiento del factor XIII para la esclerodermia.

Videos de Conceptos Relacionados

Artículos Relacionados

Modification of serum proteins during the early stages of undernutrition.

Some remarks on the research of phenylpyruvic acid in the urine.

Carbohydrate metabolism disorders in active chronic polyarthritis.

Action of the adrenochromic semicarbazone on the glycemia of normal humans.

Treatment of progressive systemic sclerosis using factor XIII.

Manganese-containing superoxide-dismutase deficiency in polymorphonuclear leukocytes of adults with rheumatoid arthritis.

Rethinking anticoagulation intensity during extracorporeal membrane oxygenation.

Standard-dose unfractionated heparin versus low-dose unfractionated heparin and low-molecular-weight heparin in extracorporeal life support (RATE): an open-label, randomised, non-inferiority trial.

Inherited retinal degenerations: clinical phenotypes and emerging therapies.

Documenting hospice care.

After the wood chipper.

Assisted dying and the silencing of medicine's next generation.